Predictive Value of Postoperative Peripheral CD4+ T Cells Percentage in Stage I–III Colorectal Cancer: A Retrospective Multicenter Cohort Study of 1028 Subjects

Predictive Value of Postoperative Peripheral CD4+ T Cells Percentage in Stage I–III Colorectal Cancer: A Retrospective Multicenter Cohort Study of 1028 Subjects

Zhenhui Li,1,* Shaoyou Li,2,* Yun Liang,3,* Hongjiang Pu,4 Changling Tu,5 Zhenyu Wu,6 Dingyun You7,8 1Department of Radiology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, Kunming 650118, People’s Republic of China; 2Department...

Full description

Bibliographic Details
Main Authors:	Li Z, Li S, Liang Y, Pu H, Tu C, Wu Z, You D
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-07-01
Series:	Cancer Management and Research
Subjects:	recurrence peripheral cd4+ t cells colorectal cancer adjuvant chemotherapy propensity score matching analysis
Online Access:	https://www.dovepress.com/predictive-value-of-postoperative-peripheral-cd4-t-cells-percentage-in-peer-reviewed-article-CMAR

Similar Items

Significance of postoperative adjuvant chemotherapy with an oxaliplatin-based regimen after simultaneous curative resection for colorectal cancer and synchronous colorectal liver metastasis: a propensity score matching analysis
by: Kiichi Sugimoto, et al.
Published: (2021-04-01)

Effectiveness of adjuvant chemotherapy in patients with Stage II colorectal cancer: A multicenter retrospective study
by: Hasan Jalaeikhoo, et al.
Published: (2019-01-01)

Postoperative adjuvant therapy following radical resection for intrahepatic cholangiocarcinoma: A multicenter retrospective study
by: Lei Wang, et al.
Published: (2020-04-01)

Survival outcomes of adjuvant taxanes, platinum plus fluoropyrimidines versus platinum and fluoropyrimidines for gastric cancer patients after D2 gastrectomy: a retrospective propensity score-matched analysis
by: Lili Wu, et al.
Published: (2021-09-01)

Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study
by: Jakob Michael Riedl, et al.
Published: (2017-06-01)

The Efficacy of S-1 as Adjuvant Chemotherapy for Resected Biliary Tract Carcinoma: A Propensity Score-Matching Analysis
by: Yoichi Miyata, et al.
Published: (2021-03-01)

Survival analysis of stage II gastric cancer patients after D2 gastrectomy: a Chinese people-based research
by: Zi-Jian Deng, et al.
Published: (2021-10-01)

Association Between Serum Carcinoembryonic Antigen Levels at Different Perioperative Time Points and Colorectal Cancer Outcomes
by: Zhenhui Li, et al.
Published: (2021-10-01)

Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
by: Gong Chen, et al.
Published: (2021-05-01)

Comparison of Peripheral Nerve Block and Spinal Anesthesia in Terms of Postoperative Mortality and Walking Ability in Elderly Hip Fracture Patients – A Retrospective, Propensity-Score Matched Study
by: Fu G, et al.
Published: (2021-05-01)

Clinicopathological features and impact of adjuvant chemotherapy on the long-term survival of patients with multiple gastric cancers: a propensity score matching analysis
by: Jian-Xian Lin, et al.
Published: (2019-02-01)

Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients
by: Bengt Glimelius, et al.
Published: (2020-08-01)

Preoperative malnutrition with mild hypoalbuminemia associated with postoperative mortality and morbidity of colorectal cancer: a propensity score matching study
by: Wan-Hsiang Hu, et al.
Published: (2019-06-01)

Recurrence Risk after Radical Colorectal Cancer Surgery—Less Than Before, but How High Is It?
by: Erik Osterman, et al.
Published: (2020-11-01)

Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer
by: Zaoqu Liu, et al.
Published: (2021-07-01)

Benefit of adjuvant chemoradiotherapy in patients with pathological stage III gastric cancer
by: Ma GF, et al.
Published: (2019-07-01)

Androgen receptor gene methylation related to colorectal cancer risk
by: Tingting Xia, et al.
Published: (2019-07-01)

Cardiotoxic Profile and Arterial Stiffness of Adjuvant Chemotherapy for Colorectal Cancer
by: Visvikis A, et al.
Published: (2020-02-01)

Essential Updates 2018/2019: Essential advances in surgical and adjuvant therapies for colorectal cancer
by: Tomonori Akagi, et al.
Published: (2020-01-01)

Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer
by: Gloria Chan, et al.
Published: (2020-11-01)

Predictive models of adjuvant chemotherapy for patients with stage ii colorectal cancer: A retrospective study
by: Bo Wei, et al.
Published: (2017-01-01)

Systemic therapy for colorectal cancer
by: Štabuc Borut
Published: (2003-01-01)

Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis
by: Daniel M. Girardi, et al.
Published: (2018-04-01)

Changes and Influential Factors of Chemotherapy Usage for Non-Small Cell Lung Cancer Patients in China: A Multicenter 10-Year (2005–2014) Retrospective Study
by: Xing PY, et al.
Published: (2020-07-01)

FIVE-YEAR CANCER-SPECIFIC SURVIVAL OF STAGE III COLORECTAL CANCER PATIENTS
by: V. Т. Kokhnyuk
Published: (2015-02-01)

The role of chemotherapy in the management of resectable colorectal cancer
by: Radosavljević Davorin Z., et al.
Published: (2003-01-01)

Exercise during adjuvant treatment for colorectal cancer: treatment completion, treatment-related toxicities, body composition, and serum level of adipokines
by: Shim YJ, et al.
Published: (2019-06-01)

Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases – the multicenter randomized controlled PUMP trial
by: F. E. Buisman, et al.
Published: (2019-04-01)

Perioperative Systemic Chemotherapy for Colorectal Liver Metastasis: Recent Updates
by: Hee Yeon Lee, et al.
Published: (2021-09-01)

Effect of chemotherapy on tumour-vessel relationship in colorectal liver metastases
by: Cimino, M., et al.
Published: (2022)

Genomic Alterations and Their Implications on Survival in Nonmetastatic Colorectal Cancer: Status Quo and Future Perspectives
by: Reetu Mukherji, et al.
Published: (2020-07-01)

Colorectal Cancer Risk in Patients with Hemorrhoids: A 10-Year Population-Based Retrospective Cohort Study
by: En-Bo Wu, et al.
Published: (2021-08-01)

Comparison of surgical and oncologic outcomes in very elderly patients (≥ 80 years old) and elderly (65–79 years old) colorectal cancer patients: a propensity score matching
by: Cheng, Y.-X, et al.
Published: (2022)

Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer
by: Chen, Y., et al.
Published: (2022)

Chemotherapy and target therapy as neo-adjuvant approach for initially unresectable colorectal liver metastases
by: Luigi Rossi, et al.
Published: (2012-06-01)

Pathologic Factors Associated with Prognosis after Adjuvant Chemotherapy in Stage II/III Microsatellite-Unstable Colorectal Cancers
by: Jung Ho Kim, et al.
Published: (2015-03-01)

A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer
by: Bangrong Cao, et al.
Published: (2017-12-01)

Early recurrence of pancreatic cancer after resection and during adjuvant chemotherapy
by: Richard Fischer, et al.
Published: (2012-01-01)

Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection?
by: Zhizhong Pan, et al.
Published: (2018-05-01)

Pramlintide, an antidiabetic, is antineoplastic in colorectal cancer and synergizes with conventional chemotherapy
by: Al-Keilani MS, et al.
Published: (2018-03-01)